ArticleMediators of inflammation2025
Impact of New Inflammation/Nutrition-Based Indicators on Prognosis in Elderly Patients With Colorectal Cancer.
Article in Mediators of inflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A CRP-Albumin-Lymphocyte (CALLY) Index-Based Nomogram for Predicting Survival After Radical Surgery for Hypopharyngeal Squamous Cell Carcinoma.Journal of inflammation research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the impact of new inflammation/nutrition-based indicators-the modified cachexia index (mCXI) on the prognosis of elderly patients with colorectal cancer and develop a nomogram model. Methods: A retrospective analysis was conducted using clinical data from patients over 70 years old diagnosed with colorectal cancer, at the Affiliated Hospital of Qingdao University between July 2018 and December 2023. Univariate and multivariate Cox regression analyses, based on overall survival (OS) and recurrence-free survival (RFS), identified independent prognostic factors. A nomogram prediction model was constructed using multivariate analysis. Results: The study included 456 patients, comprising 273 males (59.9%) and 183 females (40.1%), with a mean age of 75 years. The median follow-up was 41 months. The 1-, 3-, and 5-year OS rates were 85%, 65%, and 50%, respectively, while the 1-, 3-, and 5-year RFS rates were 80%, 55%, and 40%, respectively. Multivariate Cox regression identified age, tumor T stage, tumor N stage, and mCXI as independent factors affecting both OS and RFS. A nomogram prognostic model was developed, with area under the ROC curve (AUC) values of 0.742, 0.809, and 0.799 for 1-, 3-, and 5-year OS, respectively, and AUC values of 0.769, 0.798, and 0.797 for 1-, 3-, and 5-year RFS, respectively. Calibration curves indicated strong agreement with the ideal model and decision curve analysis confirmed the model's robust predictive accuracy. Conclusion: The mCXI serves as an independent risk factor for both RFS and OS in elderly patients with colorectal cancer. The nomogram prediction model demonstrates strong prognostic value for this patient group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.